Clin2
NCT07449156Possibly a fitNot yet recruiting

New medication for facial acne

Acne Vulgaris

Part of Skin clinical trials.

This study tests a new medication called HB0043 for people with mild to moderate facial acne. It aims to see if the treatment is safe and effective in reducing acne.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
21 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be at least 18 years old.
  • You need to have mild to moderate acne on your face.
  • You cannot use any other acne treatments during the study.
  • If you can have children, you must use reliable birth control during the study and for 3 months after.
  • You cannot have other facial skin diseases or conditions that might affect the study results.
  • You cannot have certain autoimmune diseases, recent serious infections, or active infections like tuberculosis, hepatitis B/C, or HIV.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06905210Recruiting· Phase 3
New hormonal pill for moderate acne in women

This trial tests a new combination hormonal pill (a progestogen and low-dose estrogen) to treat moderate acne in women. It may be an option if you have not had success with other acne treatments.

Itapevi, São Paulo
NCT07866105Not yet recruiting· Phase 2
Acne spray study for teens and adults

This trial is testing a new spray called B244 that you put on your face to help treat moderate to severe acne. It aims to see if it is safe, works well, and is comfortable to use.

NCT07345390Not yet recruiting· Phase 2
Cream for mild to moderate facial acne

This trial tests a cream called KR230109 for mild to moderate facial acne. The goal is to see if the cream is safe and helps reduce pimples and blackheads/whiteheads. You will be asked to use the cream as directed and attend study visits.

NCT06925386Not yet recruiting· Phase 2
Skin bacteria balance as a new acne treatment

This study tests whether balancing the skin's natural bacteria (microbiome) can be a new way to treat acne. If you have mild to moderate facial acne that keeps coming back, this trial may help find a better treatment.

Denpasar, Bali
NCT03883269Recruiting· Phase 4
Tests topical antibiotics’ anti-inflammatory effect in acne

This trial studies whether putting antibiotic creams on mild-to-moderate facial acne reduces inflammation. It may help answer whether topical erythromycin or clindamycin can improve acne-related redness and swelling.

Leiden
NCT06775314Not yet recruiting· Phase 3
Skin care products for mild to moderate acne

This study tests a new set of skin care products (a cleanser, a combination cream, and a spot cream) to see how well they work and if they are safe for people with mild to moderate acne. If you join, you will use these products as directed, and the researchers will check how your skin improves.

Jakarta, Jakarta Pusat

Hear when a new Acne Vulgaris trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.